User profiles for "author:Mandeep R. Mehra"
Mandeep R. Mehra, MBBS, MSc, FRCPBrigham and Women's Hospital and Harvard Medical School Verified email at bwh.harvard.edu Cited by 64182 |
[HTML][HTML] Extrapulmonary manifestations of COVID-19
A Gupta, MV Madhavan, K Sehgal, N Nair… - Nature medicine, 2020 - nature.com
Although COVID-19 is most well known for causing substantial respiratory pathology, it can
also result in several extrapulmonary manifestations. These conditions include thrombotic …
also result in several extrapulmonary manifestations. These conditions include thrombotic …
Omega-3 polyunsaturated fatty acids and cardiovascular diseases
Omega-3 polyunsaturated fatty acid (ω-3 PUFA) therapy continues to show great promise in
primary and, particularly in secondary prevention of cardiovascular (CV) diseases. The most …
primary and, particularly in secondary prevention of cardiovascular (CV) diseases. The most …
Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure
Obesity has reached epidemic proportions in the United States and worldwide. Considering
the adverse effects of obesity on left ventricular (LV) structure, diastolic and systolic function …
the adverse effects of obesity on left ventricular (LV) structure, diastolic and systolic function …
Endothelial cell infection and endotheliitis in COVID-19
Z Varga, AJ Flammer, P Steiger, M Haberecker… - The Lancet, 2020 - thelancet.com
Cardiovascular complications are rapidly emerging as a key threat in coronavirus disease
2019 (COVID-19) in addition to respiratory disease. The mechanisms underlying the …
2019 (COVID-19) in addition to respiratory disease. The mechanisms underlying the …
COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
HK Siddiqi, MR Mehra - The journal of heart and lung transplantation, 2020 - jhltonline.org
The onslaught of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)‒
associated disease that developed in 2019, COVID-19, has gripped the world in a pandemic …
associated disease that developed in 2019, COVID-19, has gripped the world in a pandemic …
[HTML][HTML] Cardiovascular disease, drug therapy, and mortality in Covid-19
MR Mehra, SS Desai, SR Kuy, TD Henry… - New England Journal …, 2020 - Mass Medical Soc
Abstract Background Coronavirus disease 2019 (Covid-19) may disproportionately affect
people with cardiovascular disease. Concern has been aroused regarding a potential …
people with cardiovascular disease. Concern has been aroused regarding a potential …
Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
several concerns were raised with respect to the veracity of the data and analyses
conducted by Surgisphere Corporation and its founder and our co-author, Sapan Desai, in …
conducted by Surgisphere Corporation and its founder and our co-author, Sapan Desai, in …
The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update
MR Mehra, CE Canter, MM Hannan… - The Journal of Heart …, 2016 - jhltonline.org
In 2005, the International Society for Heart and Lung Transplantation (ISHLT) Board of
Directors commissioned the development of the first International Listing Criteria for Heart …
Directors commissioned the development of the first International Listing Criteria for Heart …
Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates—2006
MR Mehra, J Kobashigawa, R Starling… - The Journal of heart …, 2006 - jhltonline.org
Two of the previous International Society for Heart and Lung Transplantation (ISHLT)
consensus conferences have addressed listing criteria for patients awaiting heart …
consensus conferences have addressed listing criteria for patients awaiting heart …
[HTML][HTML] A fully magnetically levitated left ventricular assist device
MR Mehra, N Uriel, Y Naka… - … England Journal of …, 2019 - Mass Medical Soc
Background In two interim analyses of this trial, patients with advanced heart failure who
were treated with a fully magnetically levitated centrifugal-flow left ventricular assist device …
were treated with a fully magnetically levitated centrifugal-flow left ventricular assist device …